Protedyne Appoints President, CEO and Chairman of the Board
News Feb 02, 2006
Protedyne Corporation has announced that Fran Tuttle has joined the company as President and Chief Executive Officer and will also join the company’s Board of Directors.
Protedyne also announced that Rolf Classon has been elected Chairman of the Board. Classon has served on Protedyne’s Board of Directors since August 2004.
Ms. Tuttle has over 25 years of experience in life sciences leadership. Most recently, she was Senior Vice President of Near Patient Testing at Bayer Diagnostics.
At Bayer, she was responsible for a worldwide business of $400 million. Before joining Bayer Diagnostics, she spent 20 years at Chiron Diagnostics (formerly Ciba Corning Diagnostics).
"We are very pleased to have Fran Tuttle join Protedyne," said Classon. "I have known and worked with Fran for a number of years and have great respect for her leadership ability and experience."
"Protedyne has established a strong foundation in laboratory automation and I see tremendous opportunities for growth, particularly in the diagnostics market."
"Having an industry veteran of Fran’s caliber join our team further validates Protedyne’s position as a leader in laboratory automation."
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE